TY  - JOUR 
AU  - Plano Sánchez, Ana Isabel
AU  - Velasco Roces, Lucía
AU  - Zapico García, Isabel
AU  - Lázaro López, Eva
AU  - Calleja Hernández, Miguel Ángel
AU  - Baena Parejo, Maria Isabel
AU  - Peña Díaz, Jaime
PY  - 2018
SN  - 1792-1074
UR  - http://hdl.handle.net/10481/56742
AB  - Sorafenib is an oral multikinase inhibitor with antiangiogenic and antiproliferative properties, and is used as the first‑line treatment for patients with advanced hepatocellular carcinoma (HCC). Previous studies have identified an improvement in...
LA  - eng
PB  - Spandidos Publications
KW  - Sorafenib
KW  - α‑fetoprotein
KW  - Hepatocellular carcinoma
KW  - Biomarker
KW  - Effectiveness
TI  - Value of α‑fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma
ER  -